Daniel Medic
Family Medicine · North Huntingdon, PANPI 1023000585
Payments from drug & device makers
Across 167 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$413
- Novo Nordisk$360
- Pfizer$278
- Astellas Pharma US Inc$202
- AbbVie$191
- Amgen$177
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,57596%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 21 | $413 |
| Novo Nordisk | 29 | $360 |
| Pfizer | 22 | $278 |
| Astellas Pharma US Inc | 7 | $202 |
| AbbVie(2 entities) | 14 | $191 |
| Amgen | 11 | $177 |
| Boehringer Ingelheim | 11 | $164 |
| AstraZeneca | 8 | $158 |
| Boston Scientific | 1 | $135 |
| Lilly USA, LLC | 7 | $94 |
| Eisai Inc. | 7 | $93 |
| Sanofi-aventis U.S. LLC | 6 | $90 |
| Merck | 4 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $53 |
| Novartis | 3 | $41 |
| E.r. Squibb & Sons, L.L.C. | 3 | $39 |
| GSK | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $28 |
| Nestle Healthcare Nutrition Inc. | 2 | $26 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,675 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Synjardy XrEmpagliflozin/Metformin Hcl | 12 | $7,973 |
| SynthroidLevothyroxine Sodium | 17 | $713 |
| Metoprolol Succinate | 31 | $650 |
| Rosuvastatin Calcium | 27 | $636 |
| Gabapentin | 17 | $592 |
| Atorvastatin Calcium | 76 | $588 |
| Lisinopril | 65 | $530 |
| Pantoprazole Sodium | 45 | $461 |
| Pravastatin Sodium | 23 | $408 |
| Levothyroxine Sodium | 50 | $405 |
| Amlodipine Besylate | 49 | $358 |
| Omeprazole | 19 | $267 |
| Fluticasone Propionate | 22 | $264 |
| Montelukast Sodium | 11 | $242 |
| Tamsulosin Hcl | 16 | $217 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimSynjardy Xr | $164 | $7,97312 claims |
| AbbVieSynthroid | $191 | $71317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in North Huntingdon
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.